SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Generex Biotechnology Corporation Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies